BCM
OLMA icon

Bayesian Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bayesian Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,129
Closed -$131K – 947
2024
Q2 		$131K Buy
+12,129
New +$132K 0.02% 642

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Bayesian Capital Management's OLMA Position: Q3 2024 in Review

Bayesian Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q3 2024, closing a stake of 12,129 shares — an estimated $131K sold.

Bayesian Capital Management first reported a position in OLMA in Q2 2024 and held it in 1 quarter. The position peaked at $131K in Q2 2024. 130 funds tracked by Wall St. Rank hold OLMA as of Q3 2024.

  • Bayesian Capital Management reported no remaining Olema Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 12,129 Olema Pharmaceuticals shares in Q3 2024, an estimated $131K.
  • Bayesian Capital Management first reported a position in Olema Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Olema Pharmaceuticals position peaked at $131K in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.